AU2825789A - Tumour-targeting agents and a method of targeting tumours - Google Patents

Tumour-targeting agents and a method of targeting tumours

Info

Publication number
AU2825789A
AU2825789A AU28257/89A AU2825789A AU2825789A AU 2825789 A AU2825789 A AU 2825789A AU 28257/89 A AU28257/89 A AU 28257/89A AU 2825789 A AU2825789 A AU 2825789A AU 2825789 A AU2825789 A AU 2825789A
Authority
AU
Australia
Prior art keywords
targeting
tumour
tumours
agents
targeting agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28257/89A
Inventor
Arthur Randell Bradwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2825789A publication Critical patent/AU2825789A/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
    • A61K47/6893—Pre-targeting systems involving an antibody for targeting specific cells clearing therapy or enhanced clearance, i.e. using an antibody clearing agents in addition to T-A and D-M

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU28257/89A 1987-12-10 1988-12-09 Tumour-targeting agents and a method of targeting tumours Abandoned AU2825789A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878728856A GB8728856D0 (en) 1987-12-10 1987-12-10 Tumour-locating agents & method of locating tumours
GB8728856 1987-12-10

Publications (1)

Publication Number Publication Date
AU2825789A true AU2825789A (en) 1989-07-05

Family

ID=10628287

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28257/89A Abandoned AU2825789A (en) 1987-12-10 1988-12-09 Tumour-targeting agents and a method of targeting tumours

Country Status (3)

Country Link
AU (1) AU2825789A (en)
GB (1) GB8728856D0 (en)
WO (1) WO1989005140A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267964B1 (en) 1989-08-01 2001-07-31 Affibody Technology Sweden Ab Stabilized protein or peptide conjugates able to bond albumin having extended biological half-lives
SE509359C2 (en) * 1989-08-01 1999-01-18 Cemu Bioteknik Ab Use of stabilized protein or peptide conjugates for the preparation of a drug
DK176290D0 (en) * 1990-07-24 1990-07-24 Novo Nordisk As THERAPEUTIC AND DIAGNOSTIC PREPARATION
US8038994B2 (en) 1996-05-15 2011-10-18 Quest Pharmatech Inc. Combination therapy for treating disease
US7318921B2 (en) 1996-05-15 2008-01-15 Altarex Medical Corp. Therapeutic compositions that alter the immune response
EP1085905B1 (en) 1998-06-15 2010-09-08 Quest Pharmatech Inc. Immunotherapeutic composition and method for the treatment of prostate cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271140A (en) * 1978-01-23 1981-06-02 Baxter Travenol Laboratories, Inc. Method and composition for double receptor, specific binding assays
IL82579A0 (en) * 1986-05-27 1987-11-30 Lilly Co Eli Immunoglobulin conjugates

Also Published As

Publication number Publication date
GB8728856D0 (en) 1988-01-27
WO1989005140A1 (en) 1989-06-15

Similar Documents

Publication Publication Date Title
GB2202698B (en) Microfuse and method of manufacture
AU2255888A (en) Stone destroying catheter
AU2283588A (en) Customizable circuitry
GB2221396B (en) Catheters and methods of manufacture
AU2531988A (en) Electromagnet and method of forming same
AU590640B2 (en) Dementia-improving and therapeutic agents
JPS6436602A (en) Novel o-benzyl-n-hydroxyalkyl derivative of manucure and chitosan based on o-benzyl-n-hydroxyalkylchitosan
AU2448988A (en) Targeted forms of methyltrithio antitumor agents
AU2297388A (en) Therapeutic agents
AU1487888A (en) Method for therapy of leukemias and certain other malignancies
ZA899778B (en) Reduction of piperidine-dion-derivatives and intermediates
AU2825789A (en) Tumour-targeting agents and a method of targeting tumours
AU1792188A (en) Toy figure and method of using same
YU146288A (en) Derivatives of benzimidazole-2-il-pyridinium
GB2182567B (en) Catheters and methods of making catheters
AU1450788A (en) Thiophene-2-carbox-amide derivatives and their pharmaceutical use
JPS6470453A (en) 2-hydroxybenzophenonehydrazide and derivative
JPS6450846A (en) Arylbisperfluoroalkylcarbinol and manufacture of same
AU1376588A (en) Derivative of a fibrinolytic enzyme
AU1619688A (en) Method of construction
AU8146987A (en) Massaging head and face mask
AU1921388A (en) Improved pest-combating agents and new compounds
AU1208788A (en) A protective pad and method of forming same
AU6988187A (en) Il-beta derivatives and drugs
AU1937288A (en) Oncostatic drug